share_log

Arcadia Biosciences Analyst Ratings

アルカディア・バイオサイエンスのアナリスト評価

Benzinga ·  2023/08/28 06:25
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/28/2023 177.78% HC Wainwright & Co. $15 → $10 Maintains Buy
07/24/2023 316.67% HC Wainwright & Co. → $15 Reiterates Buy → Buy
06/05/2023 316.67% HC Wainwright & Co. $18 → $15 Maintains Buy
04/14/2023 400% HC Wainwright & Co. $3 → $18 Maintains Buy
08/26/2022 -16.67% HC Wainwright & Co. $4 → $3 Maintains Buy
01/03/2022 66.67% HC Wainwright & Co. $7 → $6 Maintains Buy
06/01/2021 94.44% HC Wainwright & Co. $6 → $7 Maintains Buy
05/11/2021 25% Lake Street → $4.5 Initiates Coverage On → Buy
02/09/2021 66.67% HC Wainwright & Co. $8 → $6 Maintains Buy
11/30/2020 177.78% HC Wainwright & Co. $12 → $10 Maintains Buy
08/17/2020 233.33% HC Wainwright & Co. $14 → $12 Maintains Buy

What is the target price for Arcadia Biosciences (RKDA)?

The latest price target for Arcadia Biosciences (NASDAQ: RKDA) was reported by HC Wainwright & Co. on August 28, 2023. The analyst firm set a price target for $10.00 expecting RKDA to rise to within 12 months (a possible 177.78% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Arcadia Biosciences (RKDA)?

The latest analyst rating for Arcadia Biosciences (NASDAQ: RKDA) was provided by HC Wainwright & Co., and Arcadia Biosciences maintained their buy rating.

When is the next analyst rating going to be posted or updated for Arcadia Biosciences (RKDA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcadia Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcadia Biosciences was filed on August 28, 2023 so you should expect the next rating to be made available sometime around August 28, 2024.

Is the Analyst Rating Arcadia Biosciences (RKDA) correct?

While ratings are subjective and will change, the latest Arcadia Biosciences (RKDA) rating was a maintained with a price target of $15.00 to $10.00. The current price Arcadia Biosciences (RKDA) is trading at is $3.60, which is out of the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする